Newsroom
The improved therapy engineers the body’s immune response against HIV rather than waiting for the virus — or parts of the virus — to induce a response. (Image: A T cell infected with HIV.)
Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV-infected cells like this one.